PeptiDream
TSE:4587 Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
WA
Consensus Narrative from 7 Analysts
Advancements In Radiopharmaceutical Pipeline And Novartis Deal Will Drive Future Success
Key Takeaways Expansion of deals and strategic partnerships positions PeptiDream for substantial future revenue growth from clinical advancements and imaging collaborations. New facilities and collaborations could enhance operational efficiency, production, and earnings, with a focus on upcoming drug approvals boosting revenue.
View narrativeJP¥3.53k
FV
42.6% undervalued intrinsic discount4.28%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
1 day ago author updated this narrative